Literature DB >> 11289076

A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets.

G Musumarra1, D F Condorelli, A S Costa, M Fichera.   

Abstract

A multivariate insight into the in vitro antitumour screen database of the NCI by means of the SIMCA package allows to propose hypotheses on the mechanism of action of novel anticancer compounds. As an example, the application of multivariate analysis to the NCI standard database provided clues to the classification of drugs whose mechanism is either unknown or controversial. Moreover, the influence of intrinsic biochemical cell line properties (molecular targets) on the sensitivity to drug treatment could be evaluated simultaneously for classes of compounds which act by the same mechanism. Interestingly, the present approach can also provide a correlation between the molecular targets and the therapeutical fingerprint of novel active compounds thus suggesting specific biochemical studies for the investigation of new mechanisms of drug action and resistance. The statistical approach reported here represents a valuable tool for handling theenormous data sets deriving from recent genome-wide investigations of gene expression in the NCI cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289076     DOI: 10.1023/a:1008171426412

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  25 in total

1.  Levels of messenger-RNA coding for DNA topoisomerase-ii isoforms do not correlate with in-vitro drug-sensitivity.

Authors:  A Peters; A Smythe; L Wu; A Monks; M Boyd; R Shoemaker
Journal:  Oncol Rep       Date:  1994-09       Impact factor: 3.906

2.  Sequence and structural selectivity of nucleic acid binding ligands.

Authors:  J Ren; J B Chaires
Journal:  Biochemistry       Date:  1999-12-07       Impact factor: 3.162

Review 3.  DNA topoisomerase targeting drugs: mechanisms of action and perspectives.

Authors:  H Malonne; G Atassi
Journal:  Anticancer Drugs       Date:  1997-10       Impact factor: 2.248

4.  Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel.

Authors:  E S Woo; A Monks; S C Watkins; A S Wang; J S Lazo
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

5.  An information-intensive approach to the molecular pharmacology of cancer.

Authors:  J N Weinstein; T G Myers; P M O'Connor; S H Friend; A J Fornace; K W Kohn; T Fojo; S E Bates; L V Rubinstein; N L Anderson; J K Buolamwini; W W van Osdol; A P Monks; D A Scudiero; E A Sausville; D W Zaharevitz; B Bunow; V N Viswanadhan; G S Johnson; R E Wittes; K D Paull
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

6.  Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.

Authors:  L M Shi; Y Fan; T G Myers; P M O'Connor; K D Paull; S H Friend; J N Weinstein
Journal:  J Chem Inf Comput Sci       Date:  1998 Mar-Apr

7.  Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

Authors:  J S Lee; K Paull; M Alvarez; C Hose; A Monks; M Grever; A T Fojo; S E Bates
Journal:  Mol Pharmacol       Date:  1994-10       Impact factor: 4.436

8.  Solution structure of a quinomycin bisintercalator-DNA complex.

Authors:  H Chen; D J Patel
Journal:  J Mol Biol       Date:  1995-02-10       Impact factor: 5.469

9.  Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines.

Authors:  M A Izquierdo; R H Shoemaker; M J Flens; G L Scheffer; L Wu; T R Prather; R J Scheper
Journal:  Int J Cancer       Date:  1996-01-17       Impact factor: 7.396

10.  Neural computing in cancer drug development: predicting mechanism of action.

Authors:  J N Weinstein; K W Kohn; M R Grever; V N Viswanadhan; L V Rubinstein; A P Monks; D A Scudiero; L Welch; A D Koutsoukos; A J Chiausa
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  1 in total

1.  N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.

Authors:  Johann Hofmann; Johnny Easmon; Gerhard Puerstinger; Gottfried Heinisch; Marcel Jenny; Alexander A Shtil; Martin Hermann; Daniele F Condorelli; Salvatore Sciré; Giuseppe Musumarra
Journal:  Invest New Drugs       Date:  2008-07-09       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.